Cargando…
Circulating Tumor DNA as a Marker for Treatment Response in Metastatic Melanoma Patients Using Next-Generation Sequencing—A Prospective Feasibility Study
SIMPLE SUMMARY: Despite the improvement of the prognosis of metastatic melanoma patients through the implementation of targeted and immunotherapies, there is a need to identify biomarkers to predict and monitor treatment response. Therefore, we performed sequencing of paired melanoma tissue biopsies...
Autores principales: | Berger, Marina, Thueringer, Andrea, Franz, Doritt, Dandachi, Nadia, Talakić, Emina, Richtig, Georg, Richtig, Erika, Rohrer, Peter Michael, Koch, Lukas, Wolf, Ingrid Hildegard, Koch, Catharina, Rainer, Barbara Margaretha, Koeller, Maximilian, Pichler, Martin, Gerritsmann, Hanno, Kashofer, Karl, Aigelsreiter, Ariane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233754/ https://www.ncbi.nlm.nih.gov/pubmed/34205831 http://dx.doi.org/10.3390/cancers13123101 |
Ejemplares similares
-
Two Case Reports of Rare BRAF Mutations in Exon 11 and Exon 15 with Discussion of Potential Treatment Options
por: Richtig, Georg, et al.
Publicado: (2016) -
Function and Clinical Implications of Long Non-Coding RNAs in Melanoma
por: Richtig, Georg, et al.
Publicado: (2017) -
Predatory journals: Perception, impact and use of Beall’s list by the scientific community–A bibliometric big data study
por: Richtig, Georg, et al.
Publicado: (2023) -
Hedgehog pathway proteins SMO and GLI expression as prognostic markers in head and neck squamous cell carcinoma
por: Richtig, Georg, et al.
Publicado: (2019) -
Prediction of Response in Melanoma Therapy by Systemic Inflammatory Response – One Size Fits Not All
por: Richtig, Georg, et al.
Publicado: (2017)